A disciplined, highly targeted approach to discovering new cancer medicines
Rigorous, definitive clinical trials based on deep oncology expertise
Committed to bringing differentiated new cancer medicines to patients
ARIAD's first internally discovered and developed medicine
ARIAD Enters into Settlement Agreement with Sarissa Capital Management
ARIAD Founder, Harvey J. Berger, M.D., to Retire as Chairman and Chief Executive Officer
A shared commitment to patients and each other. This is ARIAD.